Nina Cosdon

New research identified the epidermal growth factor receptor (EGFR) is essential for hepatitis E to enter cells.

International research efforts developed recommendations to optimize, control, and validate quantitative viral DNA measurements of chronic hepatitis B in the liver.

Among male couples, HIV PrEP usage is suboptimal. Lingering stigma may be preventing men who have sex with men from using PrEP, even when in a relationship with an HIV-positive partner.

February 7 is National Black HIV/AIDS Awareness Day (#NBHAAD). In observance, we're recapping stories to raise awareness and work toward ending HIV/AIDS disparities in Black communities.

Women who made healthy lifestyle choices prior to contracting COVID-19 had a 49% reduced risk of long COVID.

New research suggests the majority of people hospitalized with influenza also had a chronic illness.

The biggest COVID-19 news from the past week.

The vast majority of COVID-19 infections are diagnosed at home, with rapid antigen tests. How has this affected public reports of COVID-19 prevalence?

New York City has ended their mpox outbreak after months of successful community outreach and vaccination campaigns.

University of Missouri investigators found people experiencing post-acute sequelae of COVID-19 (long COVID) are susceptible to developing 7 health defects in the year following infection.

Patients treated with SER-109 reported a significant improvement in disease-specific health-related quality-of-life, regardless of their clinical outcome.

This first-in-human, phase 1 vaccine trial produced a lasting immune response against Marburg virus.

COVID-19 mortalities tend to be lowest in children, but the virus is still the #8 cause of death in children and young people 0-19 years old.

These diseases, exacerbated by poor water quality, sanitation, and health care access, are highlighted today.

Patients suffering from post-acute sequelae of COVID-19, or “long COVID,” had virus-specific T cells that were more than 100 times higher than patients who fully recovered from COVID-19 infection.

Utopia Foods, Inc., issued a voluntary recall after their imported Chinese enoki mushrooms tested positive for 2 strains of Listeria monocytogenes involved in an outbreak.

The week's most-clicked COVID-19 stories included vaccine updates, new variants, and a pivotal FDA advisory committee vote.

Novavax will update its protein-based COVID-19 vaccine, but maintains the current vaccine is effective against current and future variants.

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted to move toward a unified strain composition for COVID-19 primary and booster vaccines.

Investigators identify a mechanism that’s vital to the progression of alcohol-related hepatitis, paving the way for new treatments.

If approved on its March PDUFA date, rezafungin could be the first new Candida treatment option in over a decade.

A recreation of a failed staph vaccine trial unveiled that previous exposure to S aureus made the vaccine candidate ineffective.

Rapidly distributing vaccines to at least 1/3 of at-risk populations, in addition to increasing tasting and contact tracing, may adequately stop the spread of mpox.

What factors contribute to post-COVID-19 conditions (“long COVID”)? Can vaccination before or after a COVID-19 infection decrease the risk of long COVID?

Reported reasons adults had not received a bivalent COVID-19 booster dose differed across age groups.

Click on the slideshow images to read the full stories featured in this weekly infectious disease recap.

Tenofovir alafenamide (TAF) and tenofovir disoproxil fumarate (TDF), antiretroviral drugs used to treat HIV and hepatitis B, may be simultaneously depleting the energy of immune cells.

What is the hepatitis C treatment uptake among people who inject drugs?

Sepsis is the number 1 cause of death in hospitals. The FDA approval of IntelliSep, the first sepsis diagnostic tool, could change this.

Tibetan Buddhist monks, who meditate regularly, had vastly different gut microbiomes than the non-meditating control group.